Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant Factor VIII Fc fusion protein

rFVIIIFc · Bioverativ Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Factor VIII Fc fusion protein, covering 2014-08-29 to 2014-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A [Phase 3]

See pricing